Gynuity Health Projects

Resources

Resources by Title

800μg misoprostol and mucosal and systemic immune activation or the cervicovaginal microbiome

A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes

A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol

A new formulation of misoprostol is unlikely to revolutionise postpartum haemorrhage care

A prospective open-label study of home use of mifepristone for medical abortion in Nepal

A prospective, non-randomized study of home-use of mifepristone for medical abortion in the U.S.

A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contracept

A systematic review of the relationship between blood loss and clinical signs.

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days’ LMP

Abortion and sex determination

Abortion in the Middle East and North Africa

Abortion is for women

Abortion With Self-Administered Misoprostol: A Guide For Women

Abortion: What is the problem?

Acceptability & feasibility of 400μg buccal misoprostol after 200 mg mife for early MA in Georgia

Acceptability and feasibility of medical abortion in Nepal

Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerb

Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Acceptability of home use of mifepristone for medical abortion

Achieving community-based postpartum follow up in eastern Uganda

Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial

Administration of misoprostol by trained TBAs to prevent PPH in homebirths in Pakistan

Advance misoprostol distribution for preventing and treating postpartum haemorrhage

Alternatives to mifepristone for early medical abortion

Alternatives to Routine Follow-Up for Early Medical Abortion

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Are two doses of misoprostol after mifepristone for early abortion better than one?

Armenia: A Way to Make Abortion Safer

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Blood Loss After Vaginal Delivery

Breast Cancer

Buccal misoprostol for IUFD Research Group

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss

Can mifepristone medical abortion be simplified?

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Child Health

Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru

Claims of misoprostol use based on blood sampling should be viewed with skepticism

Clinic-level introduction of medical abortion in Vietnam

Clostridium sordellii infection in medical abortion

Combined hormonal contraceptives and venous thromboembolism

Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii

Community-based kangaroo mother care to prevent neonatal and infant mortality

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

Comparison of serum markers for thrombophilia and autoimmune disease

Continuing pregnancy after mifepristone and “reversal” of first-trimester medical abortion

Contraception Program Brief

Contraceptive Implants

Controlled cord traction in active management of the third stage of labour (comment)

Cost-effectiveness of increased access to emergency contraceptive pills: probably not.

Dealing with Breast Cancer

Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion

Determining early medical abortion outcomes at 3, 7 and 14 days after mifepristone

Dissemination and implementing a core outcome set for medical and surgical abortion

DMPA and HIV: do we need a trial?

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage

Early Medical Abortion without Prior Ultrasound

Early pregnancy termination

Effect of Immediate Compared with Delayed Insertion of Etonogestrel Implants

Effects of Depot Medroxyprogesterone Acetate Injection Timing on MA Efficacy and Repeat Pregnancy

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

Embracing post-fertilisation methods of family planning: a call to action

Emergency Contraception: A Last Chance to Prevent Unintended Pregnancy

Emergency Contraceptives

Estimating contraceptive efficacy: the case of spermicides

Evaluation of efficacy, safety & acceptability of pericoital oral contraception with levonorgestrel

Evidence versus influence in the WHO procedure for approving essential medicines

Expanding Choice in Abortion Services in Armenia

Exploration of a new procedure for sterilization

Facility and personnel factors influencing magnesium sulfate use for eclampsia and preeclampsia

Family Planning

FAQ on Hormonal Contraception and HIV

FAQ on Misoprostol Detection in Blood

FAQs on Fatal Infection and Medical Abortion - Summary

FAQs on Fatal Infection and Medical Abortion - Technical Version

FAQs on the Use of Multi-level Pregnancy Tests for Medical Abortion

Female Genital Mutilation

Feticidal digoxin before D&E

Fever after treatment of postpartum hemorrhage

Fifteen years: looking back and looking forward

First experience of the use of misoprostol as post-abortion care in Libreville, Gabon.

First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review

Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India

Guidebook on Misoprostol for Treatment of Incomplete Abortion

High fever following postpartum administration of sublingual misoprostol

Home administration of misoprostol for early medical abortion in India

Home use of mifepristone and misoprostol for MA up to 10weeks of pregnancy in Kazakhstan

Home use of urine pregnancy tests for medical abortion follow-up

Hormonal contraceptive methods and risk of HIV acquisition in women

How effective are the components of active management of the third stage of labor?

ICMA Third International Conference

If we can do it for misoprostol, why not for mifepristone?

Improving Care at Delivery for Women with Preeclampsia

Improving Current Therapies and Exploring New Options in Abortifacient Technology